Find therapies in clinical trials near you – page 90

Study on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab

Study on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab

Study on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease

Study on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Study of Oral NX-13 for Patients with Moderate to Severe Ulcerative Colitis

Study of Oral NX-13 for Patients with Moderate to Severe Ulcerative Colitis

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Study on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides

Study on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease

Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Phase 3 Study of Zigakibart (BION-1301) in Adults with IgA Nephropathy

Safety, Tolerability and Pharmacokinetics of Oral PF-07293893 in Healthy Adults for Future Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)

Safety, Tolerability and Pharmacokinetics of Oral PF-07293893 in Healthy Adults for Future Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)

Relative Bioavailability of Sisunatovir Capsules vs Tablets in Fasted and Fed Conditions in Healthy Adults with Respiratory Syncytial Virus

Relative Bioavailability of Sisunatovir Capsules vs Tablets in Fasted and Fed Conditions in Healthy Adults with Respiratory Syncytial Virus